Skip Navigation


BJA Advance Access originally published online on June 11, 2004
British Journal of Anaesthesia 2004 93(2):298-300; doi:10.1093/bja/aeh196
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/2/298    most recent
aeh196v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Price, G.
Right arrow Articles by Skowronski, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Price, G.
Right arrow Articles by Skowronski, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2004

CASE REPORT

Use of recombinant factor VIIa to treat life-threatening non-surgical bleeding in a post-partum patient

G. Price*, J. Kaplan and G. Skowronski

Department of Intensive Care Medicine, St George Hospital, Kogarah, Sydney NSW 2217, Australia

* Corresponding author: E-mail grantcprice{at}hotmail.com

Ongoing bleeding from patients who have an acquired coagulopathy post-surgery is a common problem. Strategies that are available to combat this problem revolve around the replacement of coagulation factors, platelets, and red blood cells as necessary. These strategies are not always successful and a more direct approach to activating the coagulation system can be more effective and in some instances life saving. We describe the use of recombinant factor VIIa in a patient with ongoing post partum bleeding.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arch SurgHome page
M. Ranucci, G. Isgro, G. Soro, D. Conti, and B. De Toffol
Efficacy and Safety of Recombinant Activated Factor VII in Major Surgical Procedures: Systematic Review and Meta-analysis of Randomized Clinical Trials
Arch Surg, March 1, 2008; 143(3): 296 - 304.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
J. Ahonen and R. Jokela
Recombinant factor VIIa for life-threatening post-partum haemorrhage
Br. J. Anaesth., May 1, 2005; 94(5): 592 - 595.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.